NPR-A Antibodies

Santa Cruz Biotechnology provides a broad selection of NPR-A Antibodies for advanced research in the field of cardiovascular and renal physiology. NPR-A Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NPR-A, or Natriuretic Peptide Receptor A, plays a crucial role in the regulation of blood pressure and fluid balance by mediating the effects of natriuretic peptides. The receptor is essential for cardiovascular homeostasis and has implications in various pathophysiological conditions, including heart failure and hypertension. Understanding NPR-A function is vital for developing therapeutic strategies targeting cardiovascular diseases. NPR-A research continues to reveal new insights into cardiovascular regulation and potential therapeutic targets. Investigating NPR-A signaling pathways helps advance our understanding of blood pressure control mechanisms. Current research focuses on how NPR-A influences cellular responses in different tissue types. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of cardiovascular disease mechanisms and potential treatments.